Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ELRIG Announces Drug Discovery 2012 Keynotes and Workshops

Published: Tuesday, August 14, 2012
Last Updated: Tuesday, August 14, 2012
Bookmark and Share
European Laboratory Robotics Interest Group have announced details of the keynote speakers and workshop programme for its 6th Annual Drug Discovery Conference.

ELRIG is also calling for abstract submissions (posters@elrig.org) for the main poster sessions and for the SLAS Young Scientist Award, the winner of which will be awarded with an expenses paid trip to present and participate in the Student Poster Competition at SLAS2013, 12th-16th January 2013 in Florida.

Keynote presentations will be given by Dr Steve Rees, Vice-President of Screening Sciences and Sample Management at AstraZeneca, and Section President of SLAS (‘Collaborative Models for Lead Discovery’), and Dr Chris Moxham, Associate Vice President at ImClone Systems, a wholly owned subsidiary of Eli Lilly and Company (‘Eli Lilly and Co.'s Open Innovation Drug Discovery Initiative’). The keynote speakers will also close the meeting with a debate on ‘The Evolving Landscape for Drug Discovery’.

A number of vendor workshop sessions will be held during the event, as well as lunchtime ‘Informatics: Making Knowledge from Laboratory Data’ Seminars on both days of the event. The lunchtime Informatics Seminars are: ‘How best to enable externalisation of drug discovery’ and ‘Knowledge at your finger tips’.
Workshop sessions include: ‘Deeper insights – better prediction of drug safety and efficacy’ from GE Healthcare Drug Discovery Suite; and ‘Early drug de-risking with 3D-cell-culture systems’ with InSphero.

Drug Discovery 2012 is to be held on 5th – 6th September 2012 at the Manchester Central Convention Complex, and features over 100 exhibitor booths, an Innovation Zone, Media Area, Careers Zone and Dragons Den. Registration for the event is free and over 1,000 delegates are expected to attend.

To find out more and to register for the conference please visit www.ELRIG.org


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ELRIG Announces Drug Discovery 2014 Programme and Pre-Conference SLAS Short Courses
Now in its 8th year, the conference and exhibition is the largest drug discovery meeting in the UK, and is expected to attract over 1000 delegates.
Monday, August 04, 2014
ELRIG Announces Speaker Programme for Drug Discovery 2012 Conference
The 6th Annual Drug Discovery Conference, in collaboration with SLAS, will be held at Manchester Central Convention Complex on 5th – 6th September 2012.
Monday, April 30, 2012
ELRIG Drug Discovery 2011
The 5th ELRIG Drug Discovery show, held in Manchester on 7 & 8th September 2011, attracted 1,125 delegates and a record number of exhibitors.
Thursday, September 22, 2011
ELRIG Drug Discovery 2011
Preparations are well underway for the 5th Annual ELRIG Drug Discovery Conference to be held at Manchester Central on 7th & 8th September 2011.
Thursday, January 27, 2011
ELRIG Drug Discovery 2010 - Free Online Registration – Book you place Now
ELRIG, the European Laboratory Robotics Interest Group, are proud to announce that FREE registration to Drug Discovery 2010 is open online. Drug Discovery 2010 will be held at the Ricoh Arena, Coventry, UK on 1st and 2nd September 2010.
Monday, August 02, 2010
Scientific News
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Smart Material Hunts Cancers
Team has created smart material that locates and images cancer or tumour sites in tissue.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Reprogramming Lymph Nodes to Fight MS
Bioengineers work to reprogram lymph node function to fight multiple sclerosis.
Arms Race with a Superbug
Scientists have discovered that increased risk of superbug infection can be directly casued by immune system response to invading bacteria.
Genes Essential to Life Discovered
Genes critical for life are discovered in humans and mice as part of large-scale phenotyping study.
High-Capacity Nanoparticles
New type of nanoparticle can now have three or more drugs packaged within it, allowing for customised cancer therapy.
Manipulation of Liquid Crystals Could Help Control Drug-Delivery Process
Computer modeling, real-world testing yields new method.
Puttng Cells Through Their Paces
An obstacle course for human lung cells could be the answer for better testing the effectiveness of potential new drugs.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!